ArticleNature communications2026
A new core-genome MLST approach for Chlamydia trachomatis genomic surveillance and research.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A new core-genome MLST approach for Chlamydia trachomatis genomic surveillance and research.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chlamydia trachomatis causes common sexually transmitted infections. The use of whole-genome sequencing for its classification and surveillance is limited due to technical challenges and the lack of standardized typing frameworks. In particular, core-genome multilocus sequence typing (cgMLST), a scalable and portable approach widely applied to other bacterial pathogens, remains little explored for C. trachomatis. Here, we compiled and curated a diverse C. trachomatis genome dataset (1230 samples from 26 countries), including publicly available and newly generated assemblies, to develop a cgMLST system (n = 846 loci) optimized for standardized local deployment. Benchmarking assays demonstrated its high typeability and clustering congruence with core-SNP approaches and the existing online cgMLST schema (PubMLST). Our cgMLST framework recapitulated the four major evolutionary lineages of C. trachomatis and enabled in-depth exploration of global phylogenomic diversity and evolution, including intra-lineage diversity for detection and tracking of contemporary strains. By enabling a direct link between loci/alleles and specific phylogenomic/phenotypic traits, this cgMLST approach also elucidated the C. trachomatis genome-wide recombination landscape and identified lineage-specific alleles (and disrupted loci) with potential diagnostic and/or functional relevance. Our cgMLST schema is publicly available for local implementation accompanied by a hierarchical cgMLST-based nomenclature, promoting harmonized genogroup tracking across laboratories and countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.